Redouble AI
Summer 2024Scale human-in-the-loop for AI workflows in regulated industries
About Company
Redouble AI is the solution to scale human-in-the-loop for AI workflows in regulated industries. Instead of having to rely on slow and expensive human reviewers, Redouble’s clients save 80% of staff costs and significantly improve the accuracy and quality of their outputs by integrating our tool into their workflows. Addressing an $11BN market, the company is already generating revenue with its first set of clients. The founders are two serial entrepreneurs (who have built successful companies in AI and health-tech respectively) and a data engineering veteran who has written more than 120 enterprise-grade software applications.
Active Founders
Martin Bittner is the Co-Founder & CEO of Redouble AI. Before that, he was the CEO of Arctoris, a pharma workflow automation company which he co-founded and led from inception to profitability. In terms of background, Martin is a physician-scientist, having obtained his MD from the University of Freiburg in Germany, and his DPhil in Oncology as a Rhodes scholar at the University of Oxford.
Haotian received his training in physics and computational chemistry from Zhejiang University and New York University. In 2017 Haotian cofounded the AI drug discovery start-up Redesign Science as CTO, designed and built the internal computational pipeline that increased the high through put screening efficiency by 100X.
Andrey has spent 25 years in data and software engineering across Novartis and several startups. Specializing in devising and executing holistic data and software strategies, he led the development of over 120 software, data and AI applications, contributing to the successful market introduction of seven pharmaceutical products